傳奢侈品零售平台Mytheresa計劃明年初在美上市
據《彭博通訊社》引述消息指,德國奢侈品線上零售平台Mytheresa計劃於2021年初在美國上市,公司現時正與顧問合作準備潛在上市,計劃尋求10億至15億美元估值,但假期旺季的業務表現或會令其目標有所轉變,而公司亦有吸引到一些特殊目的收購公司(SPAC)的注意。
公司的投資者包括銳盛投資(ARES.US)及加偉大養老基金投資公司,而疫情下平台線上表現亦受惠,以同業Farfetch(FTCH.US)為例其股價今年已升四倍,今月亦獲阿里(09988.HK)等投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.